Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit ...